Skip to main content

Kodiak Sciences Inc.

KOD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001468748

In the last 90 days, Kodiak Sciences Inc. insiders filed 3 open-market purchases and 0 sales; 200 institutions reported holding it in 13F filings for Q2 2026, worth $2.36B in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Kodiak Sciences Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of KOD: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders131143+12
Shares41.1M42.0M+901.4K (+2.2%)
Value$313.1M$324.6M+$11.4M (+3.7%)

New holders (23)

Institutions that held Kodiak Sciences Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Sold out (11)

Institutions that held Kodiak Sciences Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of KOD in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Point72 Asset Management, L.P.541,400$4.14M
HRT Financial LP62,690$478.0K
NinePointTwo Capital56,642$432.0K
Simplex Trading, LLC17,748$135.0K
Walleye Capital LLC16,389$125.0K
Bayesian Capital Management, LP12,439$95.0K
Tudor Investment Corp Et Al11,181$85.0K
Raymond James & Associates11,155$85.0K
Tiedemann Advisors, LLC10,000$76.0K
Umb Bank N A71$1.00K
Captrust Financial Advisors47$0